tiprankstipranks
Altamira Therapeutics (CYTOF)
OTHER OTC:CYTOF
US Market
CYTOF
Altamira Therapeutics
RESEARCH TOOLSreports
Want to see CYTOF full AI Analyst Report?

Altamira Therapeutics (CYTOF) Income Statement

599 Followers

Altamira Therapeutics Income Statement

Last quarter (Q2 2023), Altamira Therapeutics's total revenue was CHF52.73K, a decrease of -63.73% from the same quarter last year. In Q2, Altamira Therapeutics's net income was CHF-2.71M. See Altamira Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
CHF 0.00CHF 305.62KCHF 63.88KCHF 174.47KCHF -56.00K
Gross Profit
CHF 0.00CHF -1.14MCHF -2.18MCHF 174.47KCHF -56.00K
Operating Expenses
CHF 6.54MCHF 24.99MCHF 14.92MCHF 5.46MCHF 7.26M
Depreciation and Amortization
CHF 5.92MCHF 118.89KCHF 76.36KCHF 20.04KCHF 30.82K
EBITDA
CHF -1.35MCHF -17.64MCHF -6.72MCHF -5.26MCHF -7.24M
Operating Income
CHF -5.92MCHF -26.13MCHF -17.10MCHF -5.28MCHF -7.26M
Other Income/Expenses
CHF -1.35MCHF -645.64KCHF -1.46MCHF -2.94MCHF 433.41K
Pretax Income
CHF -7.27MCHF -26.54MCHF -17.37MCHF -8.22MCHF -6.83M
Net Income
CHF -7.27MCHF -26.53MCHF -17.39MCHF -8.20MCHF -6.63M
Per Share Metrics
Basic EPS
CHF -14.81CHF -582.58CHF -525.13CHF -545.41CHF -455.96
Diluted EPS
CHF -14.80CHF -582.58CHF -525.13CHF -545.41CHF -455.96
Weighted Average Shares Outstanding
 491.00K 45.54K 33.12K 15.04K 14.54K
Weighted Average Shares Outstanding (Diluted)
 491.26K 45.54K 33.12K 15.04K 14.54K
Currency in CHF

Altamira Therapeutics Earnings and Revenue History